Skip to content

Study of microRNA using stored serum of subjects in clinical trial of influenza vaccine which was added AdvaxTM

Study of microRNA using stored serum of subjects in clinical trial of influenza vaccine which was added AdvaxTM - Study of microRNA using stored serum of subjects in clinical trial of influenza vaccine which was added AdvaxTM

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012979
Enrollment
10
Registered
2014-01-28
Start date
2012-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

None listed

Sponsors

National Institutes of Biomedical Innovation,Health and Nutrition
Lead Sponsor
Axine Corporation(Australia)
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: subjects whose serum is stored ,who consent to participate in this study

Exclusion criteria

Exclusion criteria: Not obtained the agreement

Design outcomes

Primary

MeasureTime frame
MicroRNA expression change in serum is measured by methods such as microRNA chip, a next-generation sequencer and qPCR.

Countries

Japan,Australia

Contacts

Public ContactKen Ishii

National Institutes of Biomedical Innovation,Health and Nutrition Laboratory of Adjuvant Innovation

kenishii@biken.osaka-u.ac.jp072-641-8043

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026